New strategy to reduce cancer drug's cardiotoxic effects
Doxorubicin (Doxo) is a widely used chemotherapeutic drug for cancer, though it can have toxic effects on the heart. A recent animal study published in The FASEB Journal investigated whether the cardioregulatory protein chromogranin ...
Apr 11, 2019
0
1